Phil Kim

Practices

Industries

Education and Clerkships

J.D., Southern Methodist University Dedman School of Law, 2011, cum laude; Executive Editor, SMU Science and Technology Law Review

B.A., University of Texas at Austin, 2007, with honors

Admissions

Texas

Court Admissions

U.S. District Court for the Eastern District of Texas

U.S. District Court for the Northern District of Texas

U.S. District Court for the Southern District of Texas

Languages

Korean

Profile

Phil Kim is an associate in the Healthcare Practice Group in the Dallas office of Haynes and Boone. His practice emphasizes transactional and regulatory healthcare matters, and his experience includes representing healthcare systems, hospitals, physician groups, and various other healthcare professionals in mergers and acquisitions, joint ventures, and operational, licensure, contractual, and administrative matters.

Phil has assisted clients on various forms of physician agreements, and has advised clients on compliance issues involving liability exposure, the Stark law, anti-kickback statutes, and HIPAA/HITECH privacy issues. He has also represented clients in a broad spectrum of litigation matters involving state and federal healthcare laws, complex business issues, employment issues, and various government agencies, including numerous state Medicaid agencies, the Texas Medical Board, and Medicare Administrative Contractors.

While in law school, Phil authored a comment titled “Navigating the Maze of End-of-Life Decisions Regarding the Rejection of Life Sustaining Treatment, Medical Futility, Physician-Assisted Death, and Abortion,” which was selected for publication and appeared in the SMU Science and Technology Law Review in the fall of 2010.

Newsletter

Health Law Vitals

Health Law Vitals - A Healthcare Newsletter from Haynes and Boone

The Haynes and Boone Health Law Vitals Newsletter explores significant developments and legislation in healthcare law. This edition discusses the FDA's regulatory oversight of stem cell therapies and regenerative medicine products, Texas telemedicine rulemaking, and the FDA’s new digital health software precertification program.

Professional and Community Activities

  • American Health Lawyers Association
  • American Bar Association, Health Law Section
  • State Bar of Texas, Health Law Section
  • Dallas Bar Association, Health Law Section
  • Dallas Asian American Bar Association

Email Disclaimer